Skip to main navigation
Tenaya Therapeutics
  • Careers at Tenaya
  • Contact Us
  • Leadership
  • Our Science
    • Platforms
    • Capabilities
    • Collaborations
    • Publications & Presentations
  • Our Programs
    • Pipeline
    • Programs
  • Patients
    • Elevating Patient Voices
    • Advocacy at Tenaya
    • Clinical Studies
    • Gene Therapy for Cardiomyopathies
    • Advocacy Partners
  • Investors
    • News & Events
      • Press Releases
      • Events & Presentations
    • Corporate Governance
      • Governance Overview
      • Board of Directors
      • Management
      • Committee Composition
    • Financial Information
      • SEC Filings
      • Quarterly Results
    • Stock Information
      • Stock Quote & Chart
      • Analyst Coverage
    • IR Resources
      • Investor FAQs
      • Contact IR
      • Email Alerts
  • HCP Resource Center
    • Genetic Medicine Primer
      • About Gene Therapy
    • TN-201 for MYBPC3– associated HCM
      • Hypertrophic Cardiomyopathy and Genetics
      • How TN-201 Works
      • MyPEAK-1 Phase 1b/2 Clinical Trial
      • Tenaya’s Non-interventional Studies for MYBPC3 HCM
      • Webinars
      • FAQ’s
    • TN-401 for PKP2– associated ARVC
      • ARVC and Genetics
      • How TN-401 works
      • RIDGE-1 Phase 1b Clinical Trial
      • Tenaya’s Non-interventional Study for PKP2-Associated ARVC
      • FAQ’s

Investor Portal

Past Events
Leerink Global Healthcare Conference
Mar 9, 2026 at 1:00 PM EDT
Click here for webcast
Interim Data from RIDGE-1 Phase 1b Clinical Trial of TN-401 in Adults with PKP2-associated ARVC
Dec 11, 2025 at 5:00 PM EST
Click here for webcast
Interim Data from RIDGE-1 Phase 1b Clinical Trial of TN-401 in Adults with PKP2-associated ARVC Presentation 3.3 MB
Interim Clinical Data from MyPEAK-1 Evaluating Safety and Early Efficacy of TN-201 in Adult Patients with MYBPC3-Associated HCM
Nov 10, 2025 at 8:00 AM EST
Click here for webcast
Interim Clinical Data from MyPEAK-1 Evaluating Safety and Early Efficacy of TN-201 in Adult Patients with MYBPC3-Associated HCM Presentation 3.5 MB
H.C. Wainwright Genetic Medicines Virtual Conference
Oct 14, 2025 at 7:00 AM EDT
Click here for webcast
Morgan Stanley 23rd Annual Global Healthcare Conference
Sep 9, 2025 from 4:50 PM to 5:25 PM EDT
Click here for webcast
Measuring Protein Expression in Cardiac Gene Therapy - KOL Webcast Event
Aug 26, 2025 from 11:30 AM to 1:00 PM EDT
Register here
Measuring Protein Expression in Cardiac Gene Therapy - KOL Webcast Event Presentation 2.8 MB
Canaccord Genuity 45th Annual Growth Conference
Aug 12, 2025 from 11:30 AM to 11:55 AM EDT
Click here for webcast
RSS Feeds
Email Alerts
Contact IR
Print

Privacy Policy | Cookie Policy | Terms of Use | Community Guidelines
© 2026 Tenaya Therapeutics. All rights reserved.